Chicago Atlantic BDC (LIEN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
14 Mar, 2026Executive summary
Focuses on senior secured lending to cannabis and other underserved sectors, leveraging a seasoned investment team and proprietary origination network, with a differentiated risk-reward profile among BDCs.
$2.7B in loans closed since inception, with $589.5M active pipeline and $289.3M total portfolio investment value as of March 31, 2025, across 31 companies, 79% in cannabis.
Completed a major loan portfolio acquisition in October 2024, significantly increasing asset base and scale.
All current debt investments are senior secured, with a gross weighted-average yield of 16.6% and no non-accruals.
Declared a $0.34 dividend for Q1 and Q2 2025, totaling $1.27 over the last four quarters.
Financial highlights
Gross investment income for Q1 2025 was $11.9 million, down from $12.7 million in Q4 2024.
Net investment income for Q1 2025 was $7.6 million ($0.34 per share), compared to $8 million ($0.35 per share) in Q4 2024.
Net assets at quarter-end were $301 million, with NAV per share at $13.19 and 22.8 million shares outstanding.
Portfolio investments at fair value totaled $289.3 million across 31 companies.
Principal repayments during Q1 2025 totaled $7.6 million.
Outlook and guidance
Management expects to ramp capital deployment with a focus on proven operators, strong markets, and robust collateral coverage.
Reviewing $590 million in potential debt transactions across 35 companies.
No significant change in deployment mix between cannabis and non-cannabis expected.
Conservative leverage strategy, with full draw on the facility resulting in a leverage ratio of 0.30x equity, well below industry peers.
Dividend increases not guided, but all income will be distributed by year-end as required.
Latest events from Chicago Atlantic BDC
- Q4 net investment income was $8.3M, with a 15.8% yield and zero non-accruals.LIEN
Q4 202519 Mar 2026 - Loan portfolio acquisition tripled net assets and expanded reach to 28 portfolio companies.LIEN
Q3 202414 Mar 2026 - Major portfolio acquisition, strong income, and a $100M credit facility fuel 2024 growth.LIEN
Q4 202414 Mar 2026 - NAV per share fell to $13.56 as a $130M+ loan portfolio acquisition approaches.LIEN
Q2 20242 Feb 2026 - Cannabis lending offers unique risk-reward and is poised for growth as capital markets evolve.LIEN
Fireside chat13 Jan 2026 - Annual meeting to vote on board re-election and auditor, with focus on cannabis lending.LIEN
Proxy Filing2 Dec 2025 - Vote on board re-election and auditor ratification at the June 2025 virtual annual meeting.LIEN
Proxy Filing2 Dec 2025 - Annual meeting to vote on director re-election and auditor ratification, with Board support.LIEN
Proxy Filing2 Dec 2025 - Q2 2025 saw strong income, high yields, and robust liquidity, fueling continued portfolio growth.LIEN
Q2 202523 Nov 2025